---
$id: https://graph.org.ai/products/commodity/51241125
$type: Product
source: UNSPSC
code: "51241125"
title: "Tafluprost"
class: "51241100"
classTitle: "Ophthalmic agents"
family: "51240000"
familyTitle: "Drugs affecting the ears, eye, nose and skin"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tafluprost

**UNSPSC Code**: 51241125
**Class**: [Ophthalmic agents](Ophthalmic agents.mdx)
**Family**: [Drugs affecting the ears, eye, nose and skin](../Drugs affecting the ears, eye, nose and skin.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a prostaglandin analogue with the molecular formula C25H34F2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1O6WQ6T7G3, chemically known as isopropyl (5z)-7-{(1r,2r,3r,5s)-2-((1e)-3,3-difluoro-4-phenoxybut-1-enyl)-3,5-dihydroxycyclopentyl}hept-5-enoate but generally known as tafluprost, which bears US NIH Compound Identifier 6433101. European Medicines Agency schedules Tafluprost in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB30776. The term TAFLUPROST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 18, No. 1, 2004, List 51). World Health Organization schedules tafluprost in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule tafluprost under HS 29375000 and SITC 54156. As of Q4 2014, TAFLUPROST remains the US FDA Preferred Term for this commodity. Tafluprost bears US NLM identifiers UMLS ID C1451502 and NCI Concept Code C87385. SMILES: FC(F)(/C=C/C1C(C(O)CC1O)C/C=C/CCCC(=O)OC(C)C)COC1CCCCC1.

